CASP3 and hepatocellular carcinoma: Since TCEE demonstrated a dual-effect on suppressing human hepatocellular cancer cells by induction of cell cycle inhibitors, P21 and P27, and activation of caspase-3, it is worth it to clarify the combination effects of TCEE integrated with conventional chemotherapy agents for liver cancer.